Entero Healthcare Solutions has informed that pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Friday, August 07, 2026, to consider, approve and take on record the Unaudited Standalone and Consolidated Financial Results (along with Limited Review Report) for the quarter ended June 30, 2026. As informed vide letter dated June 23, 2026, the trading window for dealing in the securities of the Company is closed for all designated persons and their immediate relatives with effect from July 01, 2026, and will continue to remain closed till completion of 48 hours after declaration of aforesaid results unless communicated otherwise.
The above information is a part of company's filings submitted to BSE.
